Answer
Feb 03, 2026 - 08:03 AM
This medication is used to treat metastatic solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion, when there is no known acquired resistance mutation and no alternative treatments available. NTRK gene fusion is a specific genetic change seen in some cancers, so this medication offers targeted therapy where other options may not exist.
